Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 2521 AL 2535

Mitochondrial defects: An emerging theranostic avenue towards Alzheimer's associated dysregulations

Mani S, Swargiary G, Singh M, Agarwal S, Dey A, Ojha S, Jha NK.

Life Sci. 2021 Nov 15;285:119985. doi: 10.1016/j.lfs.2021.119985. Epub 2021 Sep 27.

Accelerated Approval of Aducanumab: Where Do We Stand Now?

Barenholtz Levy H.

Ann Pharmacother. 2022 Jun;56(6):736-739. doi: 10.1177/10600280211050405. Epub 2021 Oct 1.

Probiotics as potential therapeutic options for Alzheimer's disease

Ji HF, Shen L.

Appl Microbiol Biotechnol. 2021 Oct;105(20):7721-7730. doi: 10.1007/s00253-021-11607-1. Epub 2021 Oct 1.

Exercise interventions in Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials

López-Ortiz S, Valenzuela PL, Seisdedos MM, Morales JS, Vega T, Castillo-García A, Nisticò R, Mercuri NB, Lista S, Lucia A, Santos-Lozano A.

Ageing Res Rev. 2021 Dec;72:101479. doi: 10.1016/j.arr.2021.101479. Epub 2021 Sep 30.

Mechanistic Insight into the Design of Chemical Tools to Control Multiple Pathogenic Features in Alzheimer's Disease

Han J, Du Z, Lim MH.

Acc Chem Res. 2021 Oct 19;54(20):3930-3940. doi: 10.1021/acs.accounts.1c00457. Epub 2021 Oct 4.

Mechanistic role of boswellic acids in Alzheimer's disease: Emphasis on anti-inflammatory properties

Siddiqui A, Shah Z, Jahan RN, Othman I, Kumari Y.

Biomed Pharmacother. 2021 Dec;144:112250. doi: 10.1016/j.biopha.2021.112250. Epub 2021 Oct 1.

Inhibition of Histone Deacetylase 6 (HDAC6) as a therapeutic strategy for Alzheimer's disease: A review (2010-2020)

Li Y, Sang S, Ren W, Pei Y, Bian Y, Chen Y, Sun H.

Eur J Med Chem. 2021 Dec 15;226:113874. doi: 10.1016/j.ejmech.2021.113874. Epub 2021 Sep 27.

New trends in pharmacological control of neuropsychiatric symptoms of dementia

Scuteri D, Corasaniti MT, Tonin P, Nicotera P, Bagetta G.

Curr Opin Pharmacol. 2021 Dec;61:69-76. doi: 10.1016/j.coph.2021.09.002. Epub 2021 Oct 9.

The efficacy and safety of zolpidem and zopiclone to treat insomnia in Alzheimer's disease: a randomized, triple-blind, placebo-controlled trial

Louzada LL, Machado FV, Quintas JL, Ribeiro GA, Silva MV, Mendonça-Silva DL, Gonçalves BSB, Nóbrega OT, Camargos EF.

Neuropsychopharmacology. 2022 Jan;47(2):570-579. doi: 10.1038/s41386-021-01191-3. Epub 2021 Oct 11.

The promise of exosome applications in treating central nervous system diseases

Mattingly J, Li Y, Bihl JC, Wang J.

CNS Neurosci Ther. 2021 Dec;27(12):1437-1445. doi: 10.1111/cns.13743. Epub 2021 Oct 12.

Exploring Aβ Proteotoxicity and Therapeutic Candidates Using Drosophila melanogaster

Elovsson G, Bergkvist L, Brorsson AC.

Int J Mol Sci. 2021 Sep 28;22(19):10448. doi: 10.3390/ijms221910448.

Aduhelm: The Best Hope for Alzheimer's Disease Patients or the Worst Decision the FDA Has Ever Made?

Kurkinen M, Tran L.

J Alzheimers Dis. 2021;84(3):969-971. doi: 10.3233/JAD-215105.

AD Hypotheses and Suggested Clinical Trials

Mandal PK, Samkaria A, Maroon JC.

ACS Chem Neurosci. 2021 Nov 3;12(21):3968-3971. doi: 10.1021/acschemneuro.1c00627. Epub 2021 Oct 18.

Of education and public policy: Aducanumab

Lundebjerg NE, Hollmann PA, Supiano MA.

J Am Geriatr Soc. 2022 Jan;70(1):81-84. doi: 10.1111/jgs.17523. Epub 2021 Nov 3.

Ferulic Acid in Animal Models of Alzheimer's Disease: A Systematic Review of Preclinical Studies

Wang EJ, Wu MY, Lu JH.

Cells. 2021 Oct 5;10(10):2653. doi: 10.3390/cells10102653.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias